Awards

Prof. Christian Happi Elected as a Member of the US National Academy of Medicine

Today, October 9, the United States National Academy of Medicine (NAM) announced the election of Prof. Christian Happi as an international member of the Academy. The announcement was made during the 2023 Annual Meeting of NAM. NAM elected 90 regular members and 10 international members. Election to the Academy is considered one of the highest …

Prof. Christian Happi Elected as a Member of the US National Academy of Medicine Read More »

ACEGID Wins 2021 Al-Sumait Prize for African Development

The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) is the winner of the 2021 Al-Sumait Prize for African Development. The Board of Trustees of the Al-Sumait Prize made the award announcement recently. ACEGID was awarded the prize “for its leading development of the field of infectious disease genomics, through the high-quality translational research …

ACEGID Wins 2021 Al-Sumait Prize for African Development Read More »

ACEGID Wins Nigerian Academy of Science 2021 Gold Medal Prize Award​

The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) has been awarded the 2021 Gold Medal Prize Award by the Nigerian Academy of Science (NAS). This is in recognition of the Centre’s contribution to and impact on infectious disease diagnosis, research and surveillance in Nigeria specifically and in Africa, generally. This is another …

ACEGID Wins Nigerian Academy of Science 2021 Gold Medal Prize Award​ Read More »

ACEGID Receives NIH Grant for Antimicrobial Resistance Research

The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) has received a grant award from the National Institutes of Health (NIH) of the United States for a data science-based research on antimicrobial resistance in bacteria. The grant is part of NIH’s Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) …

ACEGID Receives NIH Grant for Antimicrobial Resistance Research Read More »